FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160694104> ?p ?o ?g. }

• W2160694104 endingPage "1172" @default.
• W2160694104 startingPage "1167" @default.
• W2160694104 abstract "Correlation between the FAB classification and immunophenotype was studied in 169 consecutive adult patients with acute leukaemia (AL). The lineage of leukaemic cells could be determined in the majority of cases, whereas 3 patients (1.8%) remained unclassified. In 22 out of 71 patients (31%) with acute myeloid leukaemia (AML) FAB M1 and M2 types, and in 5 out of 16 patients (31%) with chronic myeloid leukaemia (CML) in myeloid blast crisis, leukaemic cells did not express myeloid lineage-related markers, indicating asynchronous expression of cell markers in a substantial proportion of patients. Flow cytometric two-colour immunofluorescence revealed mixed AL immunophenotype in 6 out of 169 patients (3.4%). This group included five CD2+ AML (5% of AML tested) and one undifferentiated AL expressing CD10(CALLA), CDw65(VIM-2). The former group included FAB M1, M2, M3 and M4 forms of AML with a single cell population, and an AML M2 patient with both cytochemically and immunologically two separate populations of leukaemic cells. This further illustrates the heterogeneity of the target cell(s) for leukaemogenesis and the level of differentiation of AML cells. However, there was no difference in the treatment response and the remission duration between AML patients and patients with mixed phenotype AML. Correlation between the FAB classification and immunophenotype was studied in 169 consecutive adult patients with acute leukaemia (AL). The lineage of leukaemic cells could be determined in the majority of cases, whereas 3 patients (1.8%) remained unclassified. In 22 out of 71 patients (31%) with acute myeloid leukaemia (AML) FAB M1 and M2 types, and in 5 out of 16 patients (31%) with chronic myeloid leukaemia (CML) in myeloid blast crisis, leukaemic cells did not express myeloid lineage-related markers, indicating asynchronous expression of cell markers in a substantial proportion of patients. Flow cytometric two-colour immunofluorescence revealed mixed AL immunophenotype in 6 out of 169 patients (3.4%). This group included five CD2+ AML (5% of AML tested) and one undifferentiated AL expressing CD10(CALLA), CDw65(VIM-2). The former group included FAB M1, M2, M3 and M4 forms of AML with a single cell population, and an AML M2 patient with both cytochemically and immunologically two separate populations of leukaemic cells. This further illustrates the heterogeneity of the target cell(s) for leukaemogenesis and the level of differentiation of AML cells. However, there was no difference in the treatment response and the remission duration between AML patients and patients with mixed phenotype AML." @default.
• W2160694104 created "2016-06-24" @default.
• W2160694104 creator A5008909646 @default.
• W2160694104 creator A5015792743 @default.
• W2160694104 creator A5020371791 @default.
• W2160694104 creator A5037008715 @default.
• W2160694104 creator A5044573633 @default.
• W2160694104 creator A5050935012 @default.
• W2160694104 creator A5051144421 @default.
• W2160694104 creator A5088685847 @default.
• W2160694104 creator A5089431990 @default.
• W2160694104 date "1993-01-01" @default.
• W2160694104 modified "2023-10-01" @default.
• W2160694104 title "Correlation of morphological FAB classification and immunophenotyping: Value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias" @default.
• W2160694104 cites W118434469 @default.
• W2160694104 cites W121657691 @default.
• W2160694104 cites W1508716863 @default.
• W2160694104 cites W1555883714 @default.
• W2160694104 cites W1558606623 @default.
• W2160694104 cites W1582130462 @default.
• W2160694104 cites W1588212475 @default.
• W2160694104 cites W1919339218 @default.
• W2160694104 cites W1985789061 @default.
• W2160694104 cites W1994477290 @default.
• W2160694104 cites W2013097551 @default.
• W2160694104 cites W2029673359 @default.
• W2160694104 cites W2030742210 @default.
• W2160694104 cites W2038444011 @default.
• W2160694104 cites W2044705402 @default.
• W2160694104 cites W2049117710 @default.
• W2160694104 cites W2076426515 @default.
• W2160694104 cites W2091652949 @default.
• W2160694104 cites W2095072727 @default.
• W2160694104 cites W2105317103 @default.
• W2160694104 cites W2154389646 @default.
• W2160694104 cites W2167166475 @default.
• W2160694104 cites W2175341072 @default.
• W2160694104 cites W2220256264 @default.
• W2160694104 cites W2238647955 @default.
• W2160694104 cites W2275552683 @default.
• W2160694104 cites W2293472245 @default.
• W2160694104 cites W2333745241 @default.
• W2160694104 cites W2334638778 @default.
• W2160694104 cites W2336736657 @default.
• W2160694104 cites W2337259373 @default.
• W2160694104 cites W2397615821 @default.
• W2160694104 cites W2403556849 @default.
• W2160694104 cites W2407920738 @default.
• W2160694104 cites W2409312248 @default.
• W2160694104 cites W2416309276 @default.
• W2160694104 cites W2418353167 @default.
• W2160694104 cites W2467334241 @default.
• W2160694104 cites W2469850703 @default.
• W2160694104 cites W2473913567 @default.
• W2160694104 cites W274692827 @default.
• W2160694104 cites W65362011 @default.
• W2160694104 cites W69650110 @default.
• W2160694104 cites W86828079 @default.
• W2160694104 doi "https://doi.org/10.1016/s0959-8049(05)80309-0" @default.
• W2160694104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8518029" @default.
• W2160694104 hasPublicationYear "1993" @default.
• W2160694104 type Work @default.
• W2160694104 sameAs 2160694104 @default.
• W2160694104 citedByCount "8" @default.
• W2160694104 countsByYear W21606941042015 @default.
• W2160694104 crossrefType "journal-article" @default.
• W2160694104 hasAuthorship W2160694104A5008909646 @default.
• W2160694104 hasAuthorship W2160694104A5015792743 @default.
• W2160694104 hasAuthorship W2160694104A5020371791 @default.
• W2160694104 hasAuthorship W2160694104A5037008715 @default.
• W2160694104 hasAuthorship W2160694104A5044573633 @default.
• W2160694104 hasAuthorship W2160694104A5050935012 @default.
• W2160694104 hasAuthorship W2160694104A5051144421 @default.
• W2160694104 hasAuthorship W2160694104A5088685847 @default.
• W2160694104 hasAuthorship W2160694104A5089431990 @default.
• W2160694104 hasConcept C104317684 @default.
• W2160694104 hasConcept C124964019 @default.
• W2160694104 hasConcept C127716648 @default.
• W2160694104 hasConcept C142724271 @default.
• W2160694104 hasConcept C1491633281 @default.
• W2160694104 hasConcept C159654299 @default.
• W2160694104 hasConcept C196166836 @default.
• W2160694104 hasConcept C203014093 @default.
• W2160694104 hasConcept C2777820912 @default.
• W2160694104 hasConcept C2778729363 @default.
• W2160694104 hasConcept C2779282312 @default.
• W2160694104 hasConcept C2779310769 @default.
• W2160694104 hasConcept C2908647359 @default.
• W2160694104 hasConcept C542903549 @default.
• W2160694104 hasConcept C54355233 @default.
• W2160694104 hasConcept C553184892 @default.
• W2160694104 hasConcept C55493867 @default.
• W2160694104 hasConcept C71924100 @default.
• W2160694104 hasConcept C86803240 @default.
• W2160694104 hasConcept C99454951 @default.
• W2160694104 hasConceptScore W2160694104C104317684 @default.
• W2160694104 hasConceptScore W2160694104C124964019 @default.
• W2160694104 hasConceptScore W2160694104C127716648 @default.

• next